Direct oral anticoagulant plasma levels in hospitalized COVID-19 patients treated with dexamethasone
Nicola Potere, Matteo Candeloro, Ettore Porreca, Stefano Marinari, Camilla Federici, Raffaella Auciello, Marcello Di Nisio
Topics & Concepts
MedicineHematologyDexamethasoneCoronavirus disease 2019 (COVID-19)Internal medicineOral anticoagulantAnticoagulant2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)GastroenterologyIntensive care medicineWarfarinVirologyAtrial fibrillationDiseaseOutbreakInfectious disease (medical specialty)Venous Thromboembolism Diagnosis and ManagementCOVID-19 Clinical Research StudiesAtrial Fibrillation Management and Outcomes